BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21864790)

  • 1. Self-organizing map of gene regulatory networks for cell phenotypes during reprogramming.
    Zhang L; Zheng Y; Li D; Zhong Y
    Comput Biol Chem; 2011 Aug; 35(4):211-7. PubMed ID: 21864790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells.
    Ambrosi DJ; Tanasijevic B; Kaur A; Obergfell C; O'Neill RJ; Krueger W; Rasmussen TP
    Stem Cells; 2007 May; 25(5):1104-13. PubMed ID: 17272499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
    Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
    Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
    Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
    Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared gene regulation during human somatic cell reprogramming.
    Wang X; Chen X; Zhang H; Qin W; Xue Y; Zeng F
    J Genet Genomics; 2012 Dec; 39(12):613-23. PubMed ID: 23273765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
    Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
    Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere rejuvenation during nuclear reprogramming.
    Marión RM; Blasco MA
    Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells.
    Patel SN; Wu Y; Bao Y; Mancebo R; Au-Young J; Grigorenko E
    Methods Mol Biol; 2013; 997():191-201. PubMed ID: 23546757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
    Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
    BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomics of protein complexes and their implications for cell reprograming and pluripotency.
    Sudhir PR; Kumari MP; Hsu WT; Massiot J; Chen CH; Kuo HC; Chen CH
    J Proteome Res; 2013 Dec; 12(12):5878-90. PubMed ID: 24256468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
    Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
    Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining pluripotent stem cells through quantitative proteomic analysis.
    Reiland S; Salekdeh GH; Krijgsveld J
    Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.